Raghvendra Ashok Bohara – författare

Hybrid nanostructures are nanoparticles which incorporate two or more structures. These structures may represent organic or inorganic material, but they synergistically improve the application of the material for end users. Hybrid Nanostructures for Cancer Theranostics explores how hybrid nanostructures are used in cancer treatment.

Focusing on the properties of hybrid nanostructures, the book demonstrates how their unique characteristics can be used to create more effective treatment techniques. In the second half of the book, the chapters examine how hybrid nanostructures are currently being used in practice, assessing the pros and cons of using different types of nanostructures for different treatments.

This valuable resource will allow readers to understand the core and emerging concept of functionalization, bioconjugation, hyperthermia and phototherapy of nanoparticles which allows for the greater use of hybrid nanomaterials in cancer theranostics.

Shows how the use of novel hybrid nanostructures can lead to more effective cancer treatments. Explores how hybrid nanostructures are used for different treatment types, including photo thermal therapy and drug delivery. Explains how the use of hybrid nanostructures can lead to more rapid cancer diagnosis.

Nanoengineered Drug Delivery Systems for Oral and Head & Neck Cancer: Targeting the Tumor Microenvironment explores innovative nanotechnologies designed to improve treatment outcomes for oral and head & neck cancers. The book integrates molecular design, nanotechnology, and clinical translation, emphasizing targeted drug delivery strategies that modulate the tumor microenvironment. It provides comprehensive coverage of tumor biology, early detection, molecular targets, and advanced delivery systems like liposomes and stimuli-responsive nanocarriers. The content also highlights emerging areas such as immune engineering, AI-assisted design, and clinical case studies, fostering a translational approach from laboratory research to clinical application. This resource benefits researchers, clinicians, and students by offering insights into cutting-edge nanomedicine, fostering interdisciplinary collaboration, and guiding future innovations in personalized cancer therapy and commercialization pathways.Presents an interdisciplinary approach integrating oncology, nanotechnology, and translational medicineIncludes detailed discussions on tumor microenvironment modulation, immune engineering, and AI-assisted designIncorporates clinical case studies, commercialization pathways, and emerging therapeutic strategies